Stem cell mobilization versus stem cell homing: Potential role for parathyroid hormone?

Cardiovascular Research

Volumn 77, Issue 4, 2008, Pages 612-613

  Schlüter, Klaus Dieter ^a   Schreckenberg, Rolf ^a   Wenzel, Sibylle ^a  

^a Physiologisches Institut   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PEPTIDE HORMONE; VASCULOTROPIN;

APOPTOSIS; CELL HOMING; EDITORIAL; GENE EXPRESSION REGULATION; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HORMONAL REGULATION; HUMAN; OSTEOBLAST; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STEM CELL HOMING; STEM CELL MOBILIZATION; SURVIVAL;

ANIMALS; CARDIOVASCULAR AGENTS; CELL MOVEMENT; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; PARATHYROID HORMONE; STEM CELLS; VENTRICULAR FUNCTION, LEFT;

EID: 39749164490     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn010     Document Type: Editorial

References (11)

1. Zaruba MM, Huber BC, Brunner S, Deindl E, David R, Fischer R et al. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc Res 2008;77:722-731.
2. Anversa P, Leri A, Rota M, Hosoda T, Bearzi C, Urbanek K et al. Concise review: stem cells, myocardial regeneration, and methodological arte-facts. Stem Cells 2007;25:589-601.
3. Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 2006;20:956-958.
4. Kuhlmann MT, Kirchhof P, Klocke R, Hasib L, Stypmann J, Fabritz L et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin-43 expression and arteriogenesis. J Exp Med 2006;203:87-97.
5. Schlüter K-D, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 1998;37:34-41.
6. Arakelyan KP, Syahakyan YA, Hayrapetyan LR, Khudaverdyan DN, Ingelman-Sundberg M, Mkrtchian S et al. Calcium-regulating peptide hormones and blood electrolyte balance in chronic heart failure. Regul Pept 2007;142:95-100.
7. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Eng J Med 2003;349:1216-1226.
8. Ballen KK, Shpall EJ, Avigan D, Yeap BY, Fisher DC, McDermott K et al. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol Blood Marrow Transplant 2007;13:838-843.
9. Grohé C, van Eickels M, Wenzel S, Meyer R, Degenhardt H, Doevendans PA et al. Sex-specific differences in ventricular expression and function of parathyroid hormone-related peptide. Cardiovas Res 2004;61:307-316.
10. Schlüter K-D, Katzer C, Frischkopf K, Wenzel S, Taimor G, Piper HM. Expression, release, and biological activity of parathyroid hormone-related peptide from coronary endothelial cells. Circ Res 2000;86:946-951.
11. Chen Y, Amende I, Hampton TG, Yang Y, Ke Q, Min J-Y et al. Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells. Am J Heart Circ Physiol 2006;291:H1653- H1658.